Atlas Trials

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Clinical trial NCT05575830 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05575830
Sponsor
Calmy Alexandra
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
RZV Vaccine (Shingrix ®)
Start date
2022-12-14
Primary completion
2025-04-16
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.